Literature DB >> 9684786

Platelet activation and cytokine production during hypothermic cardiopulmonary bypass--a possible correlation?

P Ferroni1, G Speziale, G Ruvolo, A Giovannelli, F M Pulcinelli, L Lenti, P Pignatelli, A Criniti, E Tonelli, B Marino, P P Gazzaniga.   

Abstract

Cardiopulmonary bypass (CPB) is associated with impaired platelet function and a systemic inflammatory response. The present study was designed to evaluate whether any correlation between platelet activation and inflammatory response during CPB exists. The results obtained from 8 patients undergoing hypothermic CPB for cardiac surgery showed the occurrence of a moderate degree of platelet activation during CPB, demonstrated by an increase of platelet CD62P expression in correlation with an increase of beta-thromboglobulin levels, with a concomitant decrease of in vitro platelet response. Plasma IL-1beta levels significantly increased during CPB, with a peak between 1 and 4 h after CPB. Similarly, IL-6 levels were elevated 30 min from CPB starting, peaked at 4 h, and remained elevated after 24 h. A direct correlation was found between plasma IL-1beta and IL-6 levels. A significant correlation between plasma IL-1beta and beta-thromboglobulin levels was also found. In turn, plasma beta-thromboglobulin levels correlated with CD62P expression on activated platelets. An inverse correlation was found between in vitro platelet aggregation and plasma IL-1beta or IL-6 levels. From the present results it may be speculated that platelet activation during CPB may contribute, through the release of IL-1beta, to activation of endothelial cells and subsequent release of other cytokines with chemotactic and pro-inflammatory properties, thus playing an important role in the inflammatory response associated with CPB.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9684786

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Effect of foreign surface pacification with albumin, aprotinin, propofol, and high-density lipoprotein.

Authors:  Eustace Fontaine; Richard Warwick; Priya Sastry; Michael Poullis
Journal:  J Extra Corpor Technol       Date:  2009-03

2.  Differential sensitivity of various markers of platelet activation with adenosine diphosphate.

Authors:  Giang Le Minh; Alina D Peshkova; Izabella A Andrianova; John W Weisel; Rustem I Litvinov
Journal:  Bionanoscience       Date:  2018-12-10

3.  Platelet Function Changes during Neonatal Cardiopulmonary Bypass Surgery: Mechanistic Basis and Lack of Correlation with Excessive Bleeding.

Authors:  Nicole M J Zwifelhofer; Rachel S Bercovitz; Regina Cole; Ke Yan; Pippa M Simpson; Alyssa Moroi; Peter J Newman; Robert A Niebler; John P Scott; Eckehard A D Stuth; Ronald K Woods; D Woodrow Benson; Debra K Newman
Journal:  Thromb Haemost       Date:  2019-11-21       Impact factor: 5.249

4.  Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study.

Authors:  Daniele Pastori; Roberto Carnevale; Cristina Nocella; Simona Bartimoccia; Marta Novo; Vittoria Cammisotto; Silvia Piconese; Maria Santulli; Fortunata Vasaturo; Francesco Violi; Pasquale Pignatelli
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.